BSE · 539230
Chemiesynth Vapi Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹19 Cr with net profit ₹-0 Cr — a -0.56% net margin, versus -2.36% the period before.
Shareholding
As of 2026-06-30
- Promoter62.35%
- Public37.65%
528 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.06× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — ESM · ESM 1. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Chemicals · ranked #127 of 159 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Pidilite Industries Ltd. | ₹1,65,890 Cr | 286.45 | 15.31 | 22.61% | 16.77% |
| Solar Industries India Ltd. | ₹1,63,606 Cr | 298.74 | 26.05 | 26.72% | 17.05% |
| SRF Ltd. | ₹78,369 Cr | 134.68 | 5.58 | 13.07% | 13.01% |
| Linde India Limited | ₹57,332 Cr | 104.57 | 13.44 | 12.87% | 21.69% |
| Gujarat Fluorochemicals Ltd. | ₹50,334 Cr | 461.91 | 6.45 | 7.3% | 11.49% |
| Godrej Industries Ltd. | ₹43,559 Cr | 98.05 | 3.9 | 11.1% | 5.58% |
| Navin Fluorine International Ltd. | ₹38,965 Cr | 183.04 | 9.8 | 16.69% | 20.02% |
| Himadri Speciality Chem Limited | ₹38,845 Cr | 193.44 | 8.25 | 15.96% | 16.12% |
| Deepak Nitrite Ltd. | ₹22,840 Cr | 103.95 | 3.91 | 9.43% | 6.98% |
| Deepak Fertilisers & Petrochemicals Corp Ltd. | ₹20,530 Cr | 147.31 | 3 | 10.77% | 6.41% |
| Chemiesynth Vapi Limited(this company) | ₹24 Cr | — | 2.36 | -9.84% | -4.67% |
AI analysis
AI-generated · google/gemini-2.5-flashChemiesynth Vapi Limited is listed on the Indian markets with a market capitalization of Rs 22 Cr. The company reported revenue of Rs 18.9 Cr and a profit margin of -466.6%. The book value per share is Rs 32.74 with an EPS of Rs 0. No dividend yield was reported. The 52-week high for the share was Rs 70.18 and the low was Rs 37.63.
Positives
- +Promoter holding is 62.35% as of June 30, 2026.
- +No promoter shares are pledged, with promoter pledge at 0%.
Negatives
- −The company reported a negative profit margin of -466.6%.
- −Net profit was negative at -Rs 0.11 Cr in Mar 2025.
- −Return on Equity (ROE) is negative at -9.84%.
- −Return on Capital Employed (ROCE) is negative at -0.23%.
- −Debt-to-equity ratio stands at 1.37.
- −The company is under ESM 1 surveillance.
Financial performance
The company's revenue has fluctuated over the last few fiscal years. Revenue decreased from Rs 20.94 Cr in Mar 2023 to Rs 16.44 Cr in Mar 2024, before increasing to Rs 18.90 Cr in Mar 2025. Net profit has been negative for the last two reported annual periods, with a loss of Rs 0.39 Cr in Mar 2024 and Rs 0.11 Cr in Mar 2025. Quarterly performance shows a net profit of Rs 0.6 Cr in Mar 2026, following losses in the preceding quarters.
Profitability & returns
Chemiesynth Vapi Limited reported a negative Return on Equity (ROE) of -9.84% and a negative Return on Capital Employed (ROCE) of -0.23%. The net profit margin was -466.6%. Earnings per share (EPS) have been negative for the past two annual periods, at -Rs 1.26 in Mar 2024 and -Rs 0.35 in Mar 2025.
Balance sheet
The company has a debt-to-equity ratio of 1.37. The book value per share stands at Rs 32.74.
Ownership & pledges
Public shareholding is 37.65%. No shares are reported as pledged by promoters. The number of shareholders as of June 30, 2026 was 528.
Regulatory & surveillance
The company is under ESM 1 surveillance measures.
Data as of — price: 2026-07-30 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.